通过限制病毒复制和抑制抗瘤免疫力,IRF7驱动对瘤性病毒疗法的耐药性
Jie Wang1, Dongping Zhang1, Yi Yang1
1State Key Laboratory of Medicinal Chemical Biology and College of Life Science, Nankai University, Tianjin, China.
Biochemical and biophysical research communications
|September 9, 2025
概括
干扰素调节因子7 (IRF7) 驱动对型病毒 (OV) 癌症治疗的耐药性. 向IRF7可以通过增强抗瘤免疫力来提高OV疗效.
科学领域:
- 瘤治疗性病毒疗法
- 癌症免疫疗法癌症免疫疗法
- 癌症耐药性的分子机制
背景情况:
- 瘤解毒病毒 (OVs) 通过瘤溶解和免疫刺激显示出癌症免疫治疗的前景.
- 瘤内在耐药性显著限制了OV治疗的有效性.
- 识别耐药机制对于改善基于OV的癌症治疗至关重要.
研究的目的:
- 研究结肠癌中对型病毒的抗性背后的分子机制.
- 确定涉及OV耐药性的关键监管机构.
- 评估针对已识别的抗性因子的治疗潜力.
主要方法:
- 建立一个抗OV的MC38结肠癌模型 (MC38OVR).
- 对抗性细胞中干扰素调节因子7 (IRF7) 表达的分析.
- 在IRF7淘汰后对病毒感染,复制和细胞毒性的体外评估.
- 在免疫能力相比免疫缺陷小鼠的OV疗效的体内评估.
- 免疫细胞标记物 (CD80,CD86,PD-L1) 和T细胞透的流细胞计分析.
主要成果:
- 干扰素调节因子7 (IRF7) 在抗OV的MC38OVR细胞中显著上调.
- 在实验室中,IRF7敲击增强了OV感染,复制和瘤细胞杀死.
- 与免疫能力强的小鼠相比,在免疫缺陷NOD小鼠中,OV疗效明显降低,突出显示了适应性免疫的作用.
- 瘤细胞表面标记物 (增加CD80/CD86,减少PD-L1) 的IRF7敲击调节,促进T细胞透和激活.
结论:
- 干扰素调节因子7 (IRF7) 是结肠癌中对型病毒的内在耐药性的关键媒介.
- 向IRF7可以通过增强病毒活性和促进抗瘤适应性免疫来克服OV耐药性.
- IRF7代表了一种有前途的治疗标,可以提高瘤性病毒免疫疗法的疗效.
相关概念视频
Rous Sarcoma Virus (RSV) and Cancer
6.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.2K
Mechanisms of Retrovirus-induced Cancers
6.9K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.9K
Experimental RNAi
7.3K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.3K
RNA Interference
27.8K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.8K
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Immune Response Against Viral Pathogens
1.8K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.8K


